Uploaded August 2021 | Updated September 2026, 2 days ago

---

In episode 11 of the Immunology Podcast, we chat with Dr. Christopher Klebanoff at the Memorial Sloan Kettering Cancer Center about his research on cell-based cancer immunotherapies, T cell receptors, and the therapeutic targeting of shared cancer neoantigens. Using single-cell sequencing, biophysical measurements of T cell receptor affinity, genetic engineering, and structural immunobiology, the Klebanoff lab aims to adapt adoptive T cell transfer for advanced solid tumors.

Subscribe today to never miss an episode!
Listen on iTunes: apple.co/3m9mZbF
Listen on Stitcher: bit.ly/2PHJ2ds
Listen on Spotify: spoti.fi/3hp6Iia
Official Website: immunologypodcast.com
Enjoy the other episodes in our full series playlist here: bit.ly/3wxEWo1

0:00 Intro and Roundup
29:25 Guest Interview
#Immunotherapy #TCells #Neoantigens

This podcast is brought to you by STEMCELL Technologies!
For a full list of products, as well as educational resources, visit our website: stemcell.com
Follow us on Twitter: bit.ly/3jW20Gv
Like us on Facebook: bit.ly/32ern07
Follow us on LinkedIn: bit.ly/32uKovJ
Subscribe to our YouTube channel: bit.ly/32f28ei